R
61
2
STI
4
-2
PDCO
69
-2
CB
44
-3
GM
65
15
IFF
38
-4
CL
50
2
IVZ
39
6
DLTR
46
6
TSCO
50
5
HST
29
-3
NAVI
27
-2
AIG
78
-2
JCI
54
3
DG
36
2
CLX
53
-2
AEE
78
-4
LUV
62
-8
CTAS
37
-3
MSI
47
4
R
61
2
STI
4
-2
PDCO
69
-2
CB
44
-3
GM
65
15
IFF
38
-4
CL
50
2
IVZ
39
6
DLTR
46
6
TSCO
50
5
HST
29
-3
NAVI
27
-2
AIG
78
-2
JCI
54
3
DG
36
2
CLX
53
-2
AEE
78
-4
LUV
62
-8
CTAS
37
-3
MSI
47
4
Financhill
Back

Givaudan SA Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
72

GVDNY
Givaudan SA

Last Price:
$88.14
Seasonality Move:
4.47%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$290.61
Seasonality Move:
3.3%
Buy
72
Givaudan SA (GVDNY) is a Buy

Is Givaudan SA a Buy, Sell or Hold?

  • The current Givaudan SA [GVDNY] share price is $88.88. The Score for GVDNY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • GVDNY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

  • The Givaudan SA share price today is $88.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GVDNY is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

GVDNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.7 Buy
Relative Strength Index (14 RSI): 47.94 Sell
Chaikin Money Flow: 2641 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.51 - 91.27) Sell
Bollinger Bands (100): (85.73 - 91.81) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

GVDNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.53 Sell
20-day SMA: 89.9 Sell
50-day SMA: 87.76 Buy
200-day SMA: 94.21 Sell
8-day EMA: 90.21 Sell
20-day EMA: 89.72 Sell
50-day EMA: 89.01 Sell
200-day EMA: 90.31 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

Givaudan SA Earnings Growth & GVDNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

Givaudan SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):